Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.190
-0.050 (-4.03%)
At close: Mar 11, 2026, 4:00 PM EDT
1.182
-0.008 (-0.71%)
After-hours: Mar 11, 2026, 7:59 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $229.67 million as of March 11, 2026. Its market cap has decreased by -44.57% in one year.
Market Cap
229.67M
Enterprise Value
260.18M
1-Year Change
-44.57%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $229.67M, an increase of 84.76%. That is a compound annual growth rate of 12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 239.32M | 29.10% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 240.94M |
| Eledon Pharmaceuticals | 234.09M |
| Sol-Gel Technologies | 232.89M |
| Protalix BioTherapeutics | 230.81M |
| Achieve Life Sciences | 228.37M |
| Canton Strategic Holdings | 228.23M |
| Voyager Therapeutics | 227.40M |
| Cartesian Therapeutics | 226.49M |